1. Stemness is Derived from Thyroid Cancer Cells
    Risheng Ma et al, 2014, Front. Endocrinol. CrossRef
  2. Thyroid Regeneration: How Stem Cells Play a Role?
    Shioko Kimura, 2014, Front. Endocrinol. CrossRef
  3. Expression of Hypoxia-Associated Protein HIF-1α in Follicular Thyroid Cancer is Associated with Distant Metastasis
    Aumayr Klaus et al, 2017, Pathol. Oncol. Res. CrossRef
  4. Cancer Stem Cells in the Thyroid
    Yuji Nagayama et al, 2016, Front. Endocrinol. CrossRef
  5. null
    Santosh K. Upadhyay et al, 2017 CrossRef
  6. DYT-40, a novel synthetic 2-styryl-5-nitroimidazole derivative, blocks malignant glioblastoma growth and invasion by inhibiting AEG-1 and NF-κB signaling pathways
    Meijuan Zou et al, 2016, Sci Rep CrossRef
  7. Cells susceptible to epithelial-mesenchymal transition are enriched in stem-like side population cells from prostate cancer
    YONG LUO et al, 2014 CrossRef
  8. HIF-1 at the crossroads of hypoxia, inflammation, and cancer.
    Kuppusamy Balamurugan, 2016, Int J Cancer CrossRef
  9. Zn(II)-curc targets p53 in thyroid cancer cells
    ALESSIA GARUFI et al, 2015 CrossRef
  10. Expression of Stanniocalcin 1 in Thyroid Side Population Cells and Thyroid Cancer Cells
    Suguru Hayase et al, 2015, Thyroid CrossRef
  11. Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer
    Marika H Tesselaar et al, 2017, J Mol Endocrinol CrossRef
  12. Novel therapeutic clues in thyroid carcinomas: The role of targeting cancer stem cells
    Alessandro Antonelli et al, 2017, Med. Res. Rev. CrossRef
  13. Hypoxia Increases Thyroid Cancer Stem Cell-Enriched Side Population
    K. Mahkamova et al, 2017, World J Surg CrossRef
  14. Hypoxic Microenvironment Induces EMT and Upgrades Stem-Like Properties of Gastric Cancer Cells
    Jinbao Guo et al, 2016, Technol Cancer Res Treat CrossRef
  15. Pigment epithelium-derived factor has a role in the progression of papillary thyroid carcinoma by affecting the HIF1α-VEGF signaling pathway
    Yichen Lv et al, 2016 CrossRef
  16. Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells
    Yong Sang Lee et al, 2018, Neoplasia CrossRef
  17. Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4
    P. Zhao et al, 2018, J Endocrinol Invest CrossRef
  18. Wnt Signaling in Thyroid Homeostasis and Carcinogenesis
    Kim Ely et al, 2018, Genes CrossRef
  19. Naturally occurring compounds in differentiation based therapy of cancer
    Sanja Mijatović et al, 2018, Biotechnology Advances CrossRef
  20. miR-200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial-mesenchymal transition in colorectal cancer
    Fateme Karimi Dermani et al, 2018, J. Cell. Biochem. CrossRef
  21. Identification and In Vitro Expansion of Buccal Epithelial Cells
    Soraya Rasi Ghaemi et al, 2018, Cell Transplant CrossRef
  22. Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas
    Floryne O. Buishand et al, 2016, Stem Cells and Development CrossRef
  23. SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
    Soo Young Kim et al, 2018, BMC Cancer CrossRef
  24. Controlling metastatic cancer: the role of phytochemicals in cell signaling.
    Andrea Kapinova et al, 2019, J Cancer Res Clin Oncol CrossRef
  25. Normal vs cancer thyroid stem cells: the road to transformation.
    M Zane et al, 2016, Oncogene CrossRef
  26. Cross-Talk between Inflammatory Mediators and the Epithelial Mesenchymal Transition Process in the Development of Thyroid Carcinoma
    Giovanna Revilla et al, 2019, IJMS CrossRef
  27. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review
    Heewa Shakib et al, 2019, Endocrine CrossRef
  28. The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
    Rhonda L. Bitting et al, 2014, Cancer Metastasis Rev CrossRef
  29. ABCG2/BCRP gene expression is related to epithelial–mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1)
    E Mato et al, 2014 CrossRef
  30. Cancer stem-like cells and thyroid cancer
    Z. Guo et al, 2014, Endocrine Related Cancer CrossRef
  31. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis
    Katarzyna Starska et al, 2015, Tumor Biol. CrossRef
  32. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis
    Thomas G. Papathomas et al, 2016, Human Pathology CrossRef
  33. null
    Wilson Wong et al, 2016 CrossRef
  34. Microcystin-LR promotes epithelial-mesenchymal transition in colorectal cancer cells through PI3-K/AKT and SMAD2.
    Yan Ren et al, 2017, Toxicol Lett CrossRef
  35. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors
    Chenlei Shi et al, 2016, PLoS ONE CrossRef
  36. Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells.
    Xiaoqing He et al, 2017, Mol Cancer CrossRef
  37. AEG-1/MTDH-activated autophagy enhances human malignant glioma susceptibility to TGF-β1-triggered epithelial-mesenchymal transition
    Meijuan Zou et al, 2016, Oncotarget CrossRef
  38. Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin‑releasing hormone receptors (Review).
    Hector Contreras Muñoz, 0 CrossRef
  39. The Possible Role of Cancer Stem Cells in the Resistance to Kinase Inhibitors of Advanced Thyroid Cancer
    Fiorenza Gianì et al, 2020, Cancers CrossRef
  40. Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.
    Veronica Veschi et al, 2020, Front Endocrinol (Lausanne) CrossRef
  41. Stem Cell Concept in Thyroid Cancer
    Cihan Zamur et al, 2020, Integr J Med Sci CrossRef
  42. null
    Gautham Chengizkhan et al, 2020 CrossRef

  43. MicroRNAs: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications


    Xiang-Qiong Wen et al, 2020, OTT CrossRef
  44. SOX2 Is a Potential Novel Marker of Undifferentiated Thyroid Carcinomas
    Wafaey Gomaa et al, 2020 CrossRef
  45. Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies
    Elisa Stellaria Grassi et al, 2021, JCM CrossRef
  46. Emerging Role and Clinicopathological Significance of AEG-1 in Different Cancer Types: A Concise Review
    Sushmitha Sriramulu et al, 2021, Cells CrossRef
  47. SEMA4D Knockdown Attenuates β-Catenin-Dependent Tumor Progression in Colorectal Cancer
    Mahsa Rezaeepoor et al, 2021, BioMed Research International CrossRef
  48. Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers
    Mi-Hyeon You et al, 2021, Cells CrossRef
  49. Impact of transforming growth factor beta 1 on normal and thyroid cancer side population cells
    Nani Md Latar et al, 2022, Endocrine CrossRef
  50. Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
    Qi Liu et al, 2022, Front. Pharmacol. CrossRef
  51. Targeted therapy and drug resistance in thyroid cancer
    Yujie Zhang et al, 2022, European Journal of Medicinal Chemistry CrossRef
  52. MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
    Amir Abbas Hamidi et al, 2022, Biomark Res CrossRef
  53. Roles of Cadherin2 in Thyroid Cancer
    Yun Chen et al, 2022, Front. Oncol. CrossRef
  54. TGF-β, to target or not to target; to prevent thyroid cancer progression?
    Isha Karnik et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  55. Targeting Autophagy in Thyroid Cancer: EMT, Apoptosis, and Cancer Stem Cells
    Tammy M. Holm et al, 2022, Front. Cell Dev. Biol. CrossRef
  56. Emerging role of circRNAs in cancer under hypoxia (Review)
    Qun Lai et al, 2022, Oncol Lett CrossRef
  57. The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness
    Marco De Martino et al, 2023, Cell Death Discov. CrossRef
  58. Characterization of EpCAM in thyroid cancer biology by three-dimensional spheroids in vitro model
    Viola Ghiandai et al, 2024, Cancer Cell Int CrossRef
  59. Cigarette Smoke-Induced Epithelial-to-Mesenchymal Transition: Insights into Cellular Mechanisms and Signaling Pathways
    Sarah Mohammed Alqithami et al, 2024, Cells CrossRef
  60. Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implications
    Xiaoxiao Li et al, 2024, Front. Immunol. CrossRef
  61. Hypoxic Cancer Cells‐Derived Exosomes Strengthen the Development of Cancer Stem Cell‐Like Properties Through Delivering LINC00665 in Thyroid Cancer Cells
    Ming Zhou et al, 2025, Cell Biology International CrossRef